Guidelines for radioiodine therapy of differentiated thyroid cancer

By M. Luster, S. Clarke, M. Dietlein, M. Lassmann, P. Lind, W. Oyen, J. Tennvall, E. Bombardieri. European Journal of Nuclear Medicine and Molecular Imaging, 2008

677 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/0e95fe30ff41fbdb743bb3632ddaa84d7a133402

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Luster
2. Sebastiano Filetti
3. G. Francis
4. S. Waguespack
5. D. Hartl
6. C. Durante
7. S. Leboulleux
8. P. Angelos

Citations in the corpus

• Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2019, background): “7 GBq) for patients with high risk of recurrence [IV, A] [710, 42].”
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer (2015, background): “Newer gamma-camera systems allow scanning as early as 72 hours after (131)I therapy (251).”
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (2009, neutral): “In 1996, the American Thyroid Association (ATA) published treatment guidelines for patients with thyroid nodules and DTC (10).”
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer (2009, neutral): “The use of laxatives may decrease radiation exposure of the bowel, particularly in patients treated after prolonged withdrawal of thyroid hormone, and vigorous oral hydration will reduce exposure of the bladder and gonads (22).”